News
A filing with the state details the Columbus job cuts for a biotech cutting more than one-third of its workforce.
A Massachusetts biotechnology company is laying off 21 employees in Durham amid a broader restructuring and pressure from federal regulators.
Shares of Sarepta Therapeutics declined 17% in early trading on Friday after another patient who had received an experimental ...
Sarepta Therapeutics said on Monday it will pause all shipments of Elevidys in the United States after two teenage boys with a rare condition called Duchenne muscular dystrophy, who had received the ...
Sarepta Therapeutics has paused U.S. shipments of its gene therapy Elevidys after two teenagers with Duchenne muscular ...
Companies sometimes miss the mark when it comes to telling employees they’re out of a job. From accidental goodbyes to ...
The FDA appears to have won its staring contest with Sarepta over shipments of Elevidys, after the company blinked and agreed ...
On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.
There were warnings to the FDA about Sarepta Therapeutics Inc. before US regulators asked the company to halt shipments of its gene therapy.
British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...
(Reuters) -Shares of Sarepta Therapeutics declined 26% to $16.17 in premarket trading on Friday on media reports of a patient death after receiving one of the company's gene therapies, making it the ...
Stocks wavered amid earnings. President Donald Trump signed the stablecoins bill in a win for the crypto industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results